Companies / Santa Cruz Biotechnology / GCK (G-6) FITC
Santa Cruz Biotechnology

GCK (G-6) FITC | Santa Cruz Biotechnology

mouse monoclonal IgG1; GCK Antibody (G-6) is an IgG1 κ mouse monoclonal GCK antibody (also designated HK4 antibody, hexokinase 4 antibody, HKIV antibody, MODY2 antibody, maturity onset diabetes of the young 2 antibody, or glucokinase (hexokinase 4) antibody) that detects the GCK protein of mouse, rat and human origin by WB, IP, IF and ELISA. GCK Antibody (G-6) is available as both the non-conjugated anti-GCK antibody form, as well as multiple conjugated forms of anti-GCK antibody, including agarose, HRP, PE, FITC and multiple Alexa Fluor® conjugates. Glucokinase (also designated hexokinase IV, HXKIV or GCK) plays a key role in the regulation of glucose-induced insulin secretion. GCK is expressed in pancreatic beta cells where it functions as the major glucose sensor of the body, determining the "set point" for insulin secretion. GCK is also expressed in the liver, where it catalyzes the first committed step in the disposal of glucose. Phosphorylation of glucose by glucokinase appears to be the rate-limiting step for glucose catabolism. A lack of glucokinase activity leads to reduced insulin secretion and hyperglycemia, and has been implicated as a cause for maturity onset diabetes of the youth (MODY). In fact, heterozygous point mutations in the gene encoding GCK have been detected in individuals suffering from MODY.

Reviews


No reviews yet

ABOUT THE COMPANY

Santa Cruz Biotechnology is a world leader in the development of products for the biomedical research market. Over the past 30+ years, the Company has focused on the ongoing development of research antibodies, siRNA and CRISPR Gene editing tools, biochemicals, labware and more recently has expanded into animal health care products. Santa Cruz Biotechnology has the highest commitment to quality and customer service.